Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

CoraDoc Tirzepatide Review: Cost, the 'Triple Free Promise' & Honest Verdict (2026)

An honest 2026 review of CoraDoc tirzepatide — low flat pricing, a free provider visit and shipping, and an unverified LegitScript claim.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Wellorithm

Four compounded formats at one price — injectable or oral dissolving tablet, semaglutide or tirzepatide.

$249/mo

Check Wellorithm availability

CoraDoc: $165/month tirzepatide and $99/month figures both appear on the site, consistent with its published flat, no-subscription program pricing. Every fact here comes from the company's own published program.

What CoraDoc is

CoraDoc is a nationwide, doctor-prescribed GLP-1 weight-loss telehealth service, offering compounded semaglutide and tirzepatide as flat, no-subscription programs across all 50 states. It publishes a full legal suite — Terms, Privacy, Refund Policy — and uses board-certified providers.

§ CoraDoc — Confirmed Pricing and the Unverified Claim

ItemStatus
Tirzepatide$165/mo
Lowest tier (longest commitment)$99/mo semaglutide
LegitScript claimStated on site; not independently verified
Verified: $165/mo, $99/mo lowest tier. LegitScript claim stated on site but not independently verified this check.

What CoraDoc costs

Tirzepatide is $165/month, with a $99/month figure also present, consistent with roster data placing that as the longest-commitment tier for semaglutide. CoraDoc's full program range runs roughly $99-$199/month, and the lowest price applies only at the longest commitment length — confirm which tier your quote reflects.

The 'Triple Free Promise'

CoraDoc markets a "Triple Free Promise": a free provider visit, free 2-day shipping, and free supplies included with every program — a genuine value-add if the individual pieces hold up, on top of HSA/FSA and Afterpay/Klarna/Affirm payment options and a full refund if not approved.

The unverified LegitScript claim

CoraDoc's site states "LegitScript Certified" prominently. This review, like prior research, could not independently verify that certification claim against LegitScript's own database — worth confirming directly if accreditation is a deciding factor for you.

The brand-vs-compounded question

CoraDoc dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

CoraDoc's real strengths: low flat pricing with no subscription required, and the "Triple Free Promise" (free provider visit, shipping, and supplies), all-50-state availability, flexible payment options, and a full refund if not approved. The trade-offs: the lowest $99 price is the longest-commitment tier, the compounding pharmacy partner isn't named, the LegitScript claim wasn't independently verified by this review, and the operating legal entity isn't clearly named on the site. As with any GLP-1 program, verify the LegitScript claim and confirm your commitment tier before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

CoraDoc's confirmed low flat pricing and full refund policy are genuine positives, but this review couldn't independently verify its LegitScript claim, and the compounding pharmacy isn't named — worth asking about directly before committing. If a verified LegitScript seal number matters more to you, compare it against Cora Health or Coby Health. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through CoraDoc?

$165/month. The full program range runs roughly $99-$199/month, with the lowest price applying only at the longest commitment length.

Is CoraDoc's LegitScript certification verified?

CoraDoc states "LegitScript Certified" prominently on its site, but this review could not independently verify that claim against LegitScript's own database.

Does CoraDoc name its compounding pharmacy?

No — the compounding pharmacy partner is not named.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.